Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,925Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13APOTEX INC

02 7JAMP PHARMA CORPORATION

03 7PRO DOC LIMITEE

04 7SANDOZ CANADA INCORPORATED

05 13TAKEDA CANADA INC

06 6TARO PHARMACEUTICALS INC

07 7TEVA CANADA LIMITED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE

Dosage Strength : 30MG

Packaging : 100

Approval Date :

Application Number : 2322951

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100

Approval Date :

Application Number : 2322978

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE

Dosage Strength : 20MG

Packaging : 100

Approval Date :

Application Number : 2347156

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging : 100

Approval Date :

Application Number : 2347164

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE

Dosage Strength : 60MG

Packaging : 100

Approval Date :

Application Number : 2347172

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE

Dosage Strength : 10MG

Packaging : 100

Approval Date :

Application Number : 2439603

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE

Dosage Strength : 70MG

Packaging : 100

Approval Date :

Application Number : 2458071

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2490226

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number : 2490234

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number : 2490242

Regulatory Info : CONTROLLED DRUGS (CDSA I)

Registration Country : Canada

blank